A citation-based method for searching scientific literature

E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen, John DeVincenzo, Miguela Caniza, Ben Youngblood, Carrie M Rosenberger, Paul G Thomas. Nat Med 2017
Times Cited: 85







List of co-cited articles
592 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
472
64

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
168
42

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
826
38

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
241
30

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
168
28

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
202
27

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
358
27

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
210
22

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Zhongfang Wang, Anli Zhang, Yanmin Wan, Xinian Liu, Chao Qiu, Xiuhong Xi, Yanqin Ren, Jing Wang, Yuan Dong, Meijuan Bao,[...]. Proc Natl Acad Sci U S A 2014
184
22

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
149
22


Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Adrienne G Randolph, Wai-Ki Yip, Emma Kaitlynn Allen, Carrie M Rosenberger, Anna A Agan, Stephanie A Ash, Yu Zhang, Tushar R Bhangale, David Finkelstein, Natalie Z Cvijanovich,[...]. J Infect Dis 2017
35
54


The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
116
21

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
57
28

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Shokouh Makvandi-Nejad, Henry Laurenson-Schafer, LiLi Wang, Dannielle Wellington, Yan Zhao, Boquan Jin, Ling Qin, Kerry Kite, Hooman K Moghadam, Chaojun Song,[...]. J Infect Dis 2018
24
66

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
240
16

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.
Nicholas M Chesarino, Temet M McMichael, Jacob S Yount. Future Microbiol 2014
42
33


Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
77
18

Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.
Michael J Ciancanelli, Sarah X L Huang, Priya Luthra, Hannah Garner, Yuval Itan, Stefano Volpi, Fabien G Lafaille, Céline Trouillet, Mirco Schmolke, Randy A Albrecht,[...]. Science 2015
224
16

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
107
16

IFITM3 requires an amphipathic helix for antiviral activity.
Nicholas M Chesarino, Alex A Compton, Temet M McMichael, Adam D Kenney, Lizhi Zhang, Victoria Soewarna, Matthew Davis, Olivier Schwartz, Jacob S Yount. EMBO Rep 2017
44
29


IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
110
15

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
73
17

Antiviral Protection by IFITM3 In Vivo.
Ashley Zani, Jacob S Yount. Curr Clin Microbiol Rep 2018
27
48

A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection.
Jie Zhou, Kelvin Kai-Wang To, Hui Dong, Zhong-Shan Cheng, Candy Choi-Yi Lau, Vincent K M Poon, Yan-Hui Fan, You-Qiang Song, Herman Tse, Kwok-Hung Chan,[...]. J Infect Dis 2012
56
21

Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, Lianchun Liang, Chi Zhang, Yanchao Dai, Yingmei Feng,[...]. J Infect Dis 2020
51
23

IFITM3 and severe influenza virus infection. No evidence of genetic association.
M López-Rodríguez, E Herrera-Ramos, J Solé-Violán, J J Ruíz-Hernández, L Borderías, J P Horcajada, E Lerma-Chippirraz, O Rajas, M Briones, M C Pérez-González,[...]. Eur J Clin Microbiol Infect Dis 2016
26
42

IFITM3 and susceptibility to respiratory viral infections in the community.
Tara C Mills, Anna Rautanen, Katherine S Elliott, Tom Parks, Vivek Naranbhai, Margareta M Ieven, Christopher C Butler, Paul Little, Theo Verheij, Chris S Garrard,[...]. J Infect Dis 2014
54
20

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
203
12

The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.
Maria A Stacey, Simon Clare, Mathew Clement, Morgan Marsden, Juneid Abdul-Karim, Leanne Kane, Katherine Harcourt, Cordelia Brandt, Ceri A Fielding, Sarah E Smith,[...]. J Clin Invest 2017
21
52

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
127
12

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
134
12

The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity.
Temet M McMichael, Lizhi Zhang, Mahesh Chemudupati, Jocelyn C Hach, Adam D Kenney, Howard C Hang, Jacob S Yount. J Biol Chem 2017
35
31

IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Nelson Lee, Bin Cao, Changwen Ke, Hongzhou Lu, Yunwen Hu, Claudia Ha Ting Tam, Ronald Ching Wan Ma, Dawei Guan, Zhaoqin Zhu, Hui Li,[...]. J Infect Dis 2017
30
36

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
66
15

The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Matthew J Gorman, Subhajit Poddar, Michael Farzan, Michael S Diamond. J Virol 2016
55
16

Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort.
Yonghong Zhang, Shokouh Makvandi-Nejad, Ling Qin, Yan Zhao, Tong Zhang, Lili Wang, Emmanouela Repapi, Stephen Taylor, Andrew McMichael, Ning Li,[...]. AIDS 2015
33
27

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
263
10

The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
412
10

Interferon-induced transmembrane protein 3 is a type II transmembrane protein.
Charles C Bailey, Hema R Kondur, I-Chueh Huang, Michael Farzan. J Biol Chem 2013
60
15

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
10

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Kevin Tartour, Xuan-Nhi Nguyen, Romain Appourchaux, Sonia Assil, Véronique Barateau, Louis-Marie Bloyet, Julien Burlaud Gaillard, Marie-Pierre Confort, Beatriz Escudero-Perez, Henri Gruffat,[...]. PLoS Pathog 2017
32
28

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
83
10

Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Xianxian Yang, Bin Tan, Xipeng Zhou, Jian Xue, Xian Zhang, Peng Wang, Chuang Shao, Yingli Li, Chaorui Li, Huiming Xia,[...]. PLoS One 2015
28
32

Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza.
Zhongshan Cheng, Jie Zhou, Kelvin Kai-Wang To, Hin Chu, Cun Li, Dong Wang, Dong Yang, Shufa Zheng, Ke Hao, Yohan Bossé,[...]. J Infect Dis 2015
98
10

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
A Danielle Iuliano, Katherine M Roguski, Howard H Chang, David J Muscatello, Rakhee Palekar, Stefano Tempia, Cheryl Cohen, Jon Michael Gran, Dena Schanzer, Benjamin J Cowling,[...]. Lancet 2018
804
10

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
211
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.